These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 15346340
21. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus. Piriou L, Chevallier S, Hutet E, Charley B, Le Potier MF, Albina E. Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856 [Abstract] [Full Text] [Related]
22. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Bauer T, Jilg W. Vaccine; 2006 Jan 30; 24(5):572-7. PubMed ID: 16171909 [Abstract] [Full Text] [Related]
23. HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. Dong Y, Denny TN. J Infect Dis; 2006 Jul 15; 194(2):168-75. PubMed ID: 16779722 [Abstract] [Full Text] [Related]
24. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle. Platt R, Coutu C, Meinert T, Roth JA. Vet Immunol Immunopathol; 2008 Mar 15; 122(1-2):8-15. PubMed ID: 18190971 [Abstract] [Full Text] [Related]
25. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells]. Hu ZY, He P, Zhang R, Fang X, Zhu FC, Qiu SH, Li HM, Wang H, Liang ZL, Zhuang H. Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul 15; 29(7):706-11. PubMed ID: 19031766 [Abstract] [Full Text] [Related]
26. Monitoring of human immunological responses to vaccinia virus. Harrop R, Ryan MG, Golding H, Redchenko I, Carroll MW. Methods Mol Biol; 2004 Jul 15; 269():243-66. PubMed ID: 15114020 [Abstract] [Full Text] [Related]
27. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response. Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS. Vaccine; 2015 Jun 12; 33(26):2990-6. PubMed ID: 25930115 [Abstract] [Full Text] [Related]
28. Absence of pharyngeal shedding of vaccinia following smallpox vaccination. Talbot TR, Peters J, Wright PF, Edwards KM. Am J Infect Control; 2007 Sep 12; 35(7):486-8. PubMed ID: 17765564 [Abstract] [Full Text] [Related]
29. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH. Vaccine; 2006 Mar 06; 24(10):1490-500. PubMed ID: 16269205 [Abstract] [Full Text] [Related]
31. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. Abate G, Eslick J, Newman FK, Frey SE, Belshe RB, Monath TP, Hoft DF. J Infect Dis; 2005 Oct 15; 192(8):1362-71. PubMed ID: 16170753 [Abstract] [Full Text] [Related]
32. Response to smallpox vaccine in persons immunized in the distant past. Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB. JAMA; 2003 Jun 25; 289(24):3295-9. PubMed ID: 12824212 [Abstract] [Full Text] [Related]
33. Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans. Erickson AL, Walker CM. J Gen Virol; 1993 Apr 25; 74 ( Pt 4)():751-4. PubMed ID: 8468558 [Abstract] [Full Text] [Related]
34. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. Terajima M, Cruz J, Raines G, Kilpatrick ED, Kennedy JS, Rothman AL, Ennis FA. J Exp Med; 2003 Apr 07; 197(7):927-32. PubMed ID: 12668642 [Abstract] [Full Text] [Related]
35. Ocular complications in the Department of Defense Smallpox Vaccination Program. Fillmore GL, Ward TP, Bower KS, Dudenhoefer EJ, Grabenstein JD, Berry GK, Madigan WP. Ophthalmology; 2004 Nov 07; 111(11):2086-93. PubMed ID: 15522376 [Abstract] [Full Text] [Related]
36. Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection. Kan VL, Manischewitz J, King LR, Golding H. AIDS; 2007 Feb 19; 21(4):521-4. PubMed ID: 17301573 [Abstract] [Full Text] [Related]
37. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Greenberg RN, Kennedy JS, Clanton DJ, Plummer EA, Hague L, Cruz J, Ennis FA, Blackwelder WC, Hopkins RJ. Lancet; 2007 Feb 19; 365(9457):398-409. PubMed ID: 15680454 [Abstract] [Full Text] [Related]
38. Bioterrorism. Smallpox vaccinations: how much protection remains? Cohen J. Science; 2001 Nov 02; 294(5544):985. PubMed ID: 11691969 [No Abstract] [Full Text] [Related]
39. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine. Wong-Chew RM, Beeler JA, Audet S, Santos JI. J Med Virol; 2003 Jun 02; 70(2):276-80. PubMed ID: 12696117 [Abstract] [Full Text] [Related]
40. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V. Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):230-9. PubMed ID: 18372050 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]